Ep. 315 Private Equity's Impact on Urology Practices with Dr. Benjamin Lowentritt

0:00-48:45

What opportunities and challenges does private equity bring to urology practices, and how can physicians engage in ways that strengthen their practice and preserve clinical priorities? On this episode of BackTable Urology, Dr. Ruchika Talwar interviews Dr. Benjamin Lowentritt of Chesapeake Urology and United Urology Group to unpack the realities of private equity involvement in medicine. They discuss the motivations behind consolidation, the role of management services organizations, and strategies for building mutually beneficial partnerships while upholding physician autonomy and patient care. --- Get the BackTable app https://www.backtable.com/app --- Timestamps 00:00 - Introduction 02:58 - Why Urology Drew Private Equity 07:06 - Bad Headlines vs. Reality 11:14 - MSOs and Contracts Explained 15:24 - Timelines and After Private Equity 22:47 - Efficiency and Autonomy Fears 27:15 - Why Private Equity Gets Vilified 31:23 - Young Urologist Job Market 35:42 - Advice for New Grads 40:26 - Urology in 2035 and Fair Critiques of Private Equity 44:40 - Closing Thoughts --- More about this episode Dr. Lowentritt outlines the history of private equity in healthcare, noting that consolidation predated private equity and was driven by payer and hospital market power, reimbursement pressure, administrative burden, staffing, and capital needs.

Publisher

BackTable Urology

Published

July 10, 2026

Duration

49 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

BackTable Inc.

BU

BackTable Urology

@backtableurology

#privateequitysimpact #urologypractices #benjaminlowentritt #medicine

The Nile